Rpg Life Sciences Received

Rediff.com » News » Rpg Life Sciences Received

News for Rpg Life Sciences Received

Business

Sensex ends shy of 26K ahead of US Fed meet; Metal shares drag

Markets have closed the session on a marginally lower note as investors remained cautious ahead of unscheduled expedited meet of the US Federal Reserve later in the day. The derivatives expiry for......

Markets pare gains to end flat; auto, IT gain, aviation stocks fall

The 30-share Sensex ended up 27 points at 25,868 after hitting a high of 26,059 and 50-share Nifty ended up 14 points at 7,857. Indian equities erased early gains to end flat amid profit taking in......

US drug regulator finds Indian companies critically ill

The Indian pharmaceutical industry appears to be in the line of fire. The country’s drug companies have attracted the highest number of enforcements from the American drug regulator in 2013,......

US FDA tightens regulatory noose on Indian drug firms

Import alert on Ranbaxy’s Mohali unit; Strides’ injectible arm gets warning letter Indian drug makers have again come under the scrutiny of the US Food and Drug Administration (US FDA),......

Sensex ends shy of 20,000; ITC, HDFC surge

Markets extended gains on Wednesday with the Sensex briefly crossing the 20,000 mark in intra-day trades, amid strong global cues, led by ITC and HDFC group shares. The Congress victory in......

Rediff News

Rpg Life Sciences Received

News for Rpg Life Sciences Received

Sensex ends shy of 26K ahead of US Fed meet; Metal shares drag

Markets pare gains to end flat; auto, IT gain, aviation stocks fall

US drug regulator finds Indian companies critically ill

US FDA tightens regulatory noose on Indian drug firms

Sensex ends shy of 20,000; ITC, HDFC surge

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS